Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Regeneron Pharmaceuticals
(NQ:
REGN
)
890.68
-15.86 (-1.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Regeneron Pharmaceuticals
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
30
31
Next >
Why Catalent Stock Flopped Today
June 28, 2023
The company takes the fall for a failed drug application.
Via
The Motley Fool
Why Regeneron Stock Is Trading Lower Today
June 28, 2023
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares continue to fall Wednesday after news Tuesday that the FDA issued a Complete Response Letter (CRL) for aflibercept 8 mg Biologics License...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2023
June 28, 2023
Via
Benzinga
Check Out What Whales Are Doing With REGN
June 28, 2023
Via
Benzinga
Where Regeneron Pharmaceuticals Stands With Analysts
June 27, 2023
Via
Benzinga
Amazon.com To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Wednesday
June 28, 2023
Deutsche Bank cut the price target for Walgreens Boots Alliance, Inc. (NASDAQ: WBA) from $46 to $34. Deutsche Bank analyst George Hill downgraded the stock from Buy to Hold. Walgreens shares fell 0.2%...
Via
Benzinga
Why Regeneron Stock Is Falling Today
June 27, 2023
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) shares fell after the FDA issued a Complete Response Letter (CRL) for aflibercept 8 mg Biologics License application due to an ongoing review of...
Via
Benzinga
Regeneron Stock Crumbles After FDA Rejects Its Next Blockbuster Contender
June 27, 2023
The FDA still needs to review its inspection of a third-party facility, Regeneron said late Tuesday.
Via
Investor's Business Daily
Large Cap Biopharma Buffeted By Big Gov, Choppy Days Ahead
June 26, 2023
After a huge run-up in stocks since January investors have come to realize that most of the gains have come from the so-called “Magnificent Seven” tech stocks.
Via
Talk Markets
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
June 22, 2023
Via
Benzinga
18 Analysts Have This to Say About Regeneron Pharmaceuticals
June 09, 2023
Via
Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 10 Years
June 07, 2023
Via
Benzinga
Regeneron Pharmaceuticals Unusual Options Activity For June 05
June 05, 2023
Via
Benzinga
Regeneron Pharmaceuticals Unusual Options Activity
May 30, 2023
Via
Benzinga
Biotech And Healthcare Stocks Lagging
June 21, 2023
Healthcare is a laggard with XLV down YTD but UNH is still a core position.
Via
Talk Markets
2 Biotech Stocks You Can Buy and Hold for the Next Decade
June 21, 2023
Gilead and Regeneron Pharmaceuticals both had triple-digit percentage growth over the past decade.
Via
The Motley Fool
How to Retire Rich: Biotech Stocks Edition
June 18, 2023
Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.
Via
InvestorPlace
How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities
June 17, 2023
The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators...
Via
Talk Markets
EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035
June 14, 2023
JonesResearch has initiated coverage of ophthalmic biopharmaceutical company EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) with a Buy rating and
Via
Benzinga
Regeneron Reveals Updated Data From Multiple Myeloma Study, Showing Response Rate Of 71%
May 26, 2023
Via
Benzinga
Regeneron Pharmaceuticals Unusual Options Activity For May 25
May 25, 2023
Via
Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
May 22, 2023
Via
Benzinga
2 Stocks to Buy No Matter What Happens in June and Beyond
June 14, 2023
A lot could go wrong in the next few months, but investors should largely ignore all that noise.
Via
The Motley Fool
3 Biotech Stocks to Sell in June Before They Crash and Burn
June 06, 2023
Investors should get out of these biotech stocks to sell now that the Covid-19 pandemic is largely over. These's worse in store for them.
Via
InvestorPlace
Wall Street Says These 2 Stocks May Double. Should You Buy Them?
June 05, 2023
Both of these stocks have declined over the past year.
Via
The Motley Fool
A Good Week For The Market But A Pause In The Biotech Rally
May 22, 2023
Healthcare stocks have been lagging in 2023 with the XLV down 1.97% MTD and 3.34% YTD with CVS and UNH contributing to the weakness.
Via
Talk Markets
Sanofi-Regeneron Highlight Dupixent Data, Say Drug Benefit Was Swift, Sustained
May 22, 2023
Via
Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
May 19, 2023
Via
Benzinga
How Is The Market Feeling About Regeneron Pharmaceuticals?
May 15, 2023
Via
Benzinga
The 7 Growth Stocks You Need to Own Now for Maximum Returns
May 17, 2023
If you still want to stick around in the market for max returns, these growth stocks to buy should be intriguing for speculators.
Via
InvestorPlace
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.